Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Mar;59(3):453–459. doi: 10.1038/bjc.1989.93

Subsequent primary cancers in relation to treatment of ovarian cancer.

P Prior 1, D J Pope 1
PMCID: PMC2247082  PMID: 2784687

Abstract

The incidence of subsequent primary cancers was assessed in relation to treatment for a cohort of 7,203 patients from the Birmingham and West Midlands Cancer Registry diagnosed between 1957 and 1976. The total of 213 cancers observed one or more years after treatment for ovarian cancer (mean follow-up = 6.5 person-years) represented a significant excess (observed (O) = 213, expected (E) = 140.07, relative risk (RR) = 1.5, 95% CI 1.3-1.7, P less than 0.001). Among patients whose treatment included chemotherapy (CT), with or without radiotherapy (RT), the risk of acute and non-lymphocytic leukaemia (A + NLL) was significantly increased (O = 5, E = 0.18, RR = 27.8, 95% CI 9.0-64.8, P less than 0.001). The relative risks of A + NLL following RT without CT (RR = 4.5) and after other treatments (RR = 2.9) were not significantly in excess of 1.0. Significant excesses of subsequent cancers were observed at several sites: breast (RR = 1.7, 95% CI 1.3-2.2), lung (RR = 2.0, 95% CI 1.3-3.4), colon and rectum (RR = 1.6, 95% CI 1.1-2.3), urinary system (RR = 1.9, 95% CI 0.9-3.7), nervous system (RR = 3.3, 95% CI 1.2-7.3) and connective tissue (RR = 6.7, 95% CI 1.8-17.1) but the relationship with type of treatment was not so clearly defined as that for leukaemia. Although the treatment groups were broad and based on routinely collected data, they can enhance the use of cohort analyses for exploratory and monitoring purposes.

Full text

PDF
453

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boice J. D., Jr, Blettner M., Kleinerman R. A., Stovall M., Moloney W. C., Engholm G., Austin D. F., Bosch A., Cookfair D. L., Krementz E. T. Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst. 1987 Dec;79(6):1295–1311. [PubMed] [Google Scholar]
  2. Coleman M. P., Bell C. M., Fraser P. Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study. Br J Cancer. 1987 Sep;56(3):349–355. doi: 10.1038/bjc.1987.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Coleman M., Douglas A., Hermon C., Peto J. Cohort study analysis with a FORTRAN computer program. Int J Epidemiol. 1986 Mar;15(1):134–137. doi: 10.1093/ije/15.1.134. [DOI] [PubMed] [Google Scholar]
  4. Curtis R. E., Hoover R. N., Kleinerman R. A., Harvey E. B. Second cancer following cancer of the female genital system in Connecticut, 1935-82. Natl Cancer Inst Monogr. 1985 Dec;68:113–137. [PubMed] [Google Scholar]
  5. Darby S. C., Doll R., Gill S. K., Smith P. G. Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer. 1987 Feb;55(2):179–190. doi: 10.1038/bjc.1987.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. De Gramont A., Remes P., Krulik M., Smadja N., Drolet Y., Donadio D., Louvet C., Brissaud P., Sirinelli A., Dray C. Acute leukemia after treatment for ovarian cancer. Report of four cases and review of the literature. Oncology. 1986;43(3):165–172. doi: 10.1159/000226357. [DOI] [PubMed] [Google Scholar]
  7. Greene M. H., Boice J. D., Jr, Greer B. E., Blessing J. A., Dembo A. J. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. N Engl J Med. 1982 Dec 2;307(23):1416–1421. doi: 10.1056/NEJM198212023072302. [DOI] [PubMed] [Google Scholar]
  8. Hoar S. K., Wilson J., Blot W. J., McLaughlin J. K., Winn D. M., Kantor A. F. Second cancer following cancer of the digestive system in Connecticut, 1935-82. Natl Cancer Inst Monogr. 1985 Dec;68:49–82. [PubMed] [Google Scholar]
  9. Kaldor J. M., Day N. E., Band P., Choi N. W., Clarke E. A., Coleman M. P., Hakama M., Koch M., Langmark F., Neal F. E. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer. 1987 May 15;39(5):571–585. doi: 10.1002/ijc.2910390506. [DOI] [PubMed] [Google Scholar]
  10. Kato H., Schull W. J. Studies of the mortality of A-bomb survivors. 7. Mortality, 1950-1978: Part I. Cancer mortality. Radiat Res. 1982 May;90(2):395–432. [PubMed] [Google Scholar]
  11. Kinlen L. J., Peto J., Doll R., Sheil A. G. Cancer in patients treated with immunosuppressive drugs. Br Med J (Clin Res Ed) 1981 Feb 7;282(6262):474–474. doi: 10.1136/bmj.282.6262.474-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kinlen L. J., Sheil A. G., Peto J., Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J. 1979 Dec 8;2(6203):1461–1466. doi: 10.1136/bmj.2.6203.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lynge E., Jensen O. M., Carstensen B. Second cancer following cancer of the digestive system in Denmark, 1943-80. Natl Cancer Inst Monogr. 1985 Dec;68:277–308. [PubMed] [Google Scholar]
  14. Mattison D. R., Thorgeirsson S. S. Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet. 1978 Jan 28;1(8057):187–188. doi: 10.1016/s0140-6736(78)90617-7. [DOI] [PubMed] [Google Scholar]
  15. Preston D. L., Kato H., Kopecky K., Fujita S. Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982. Radiat Res. 1987 Jul;111(1):151–178. [PubMed] [Google Scholar]
  16. Prior P., Pope D. J. Hodgkin's disease: subsequent primary cancers in relation to treatment. Br J Cancer. 1988 Oct;58(4):512–517. doi: 10.1038/bjc.1988.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Prior P., Waterhouse J. A. Multiple primary cancers of breast and cervix uteri: an epidemiological approach to analysis. Br J Cancer. 1981 May;43(5):623–631. doi: 10.1038/bjc.1981.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Prior P., Waterhouse J. A. Multiple primary cancers of the breast and ovary. Br J Cancer. 1981 Nov;44(5):628–636. doi: 10.1038/bjc.1981.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Reimer R. R., Hoover R., Fraumeni J. F., Jr, Young R. C. Second primary neoplasms following ovarian cancer. J Natl Cancer Inst. 1978 Nov;61(5):1195–1197. doi: 10.1093/jnci/61.5.1195. [DOI] [PubMed] [Google Scholar]
  20. Schoenberg B. S., Christine B. W. The association of neoplasms of the colon and rectum with primary malignancies of other sites. Am J Proctol. 1974 Aug;25(4):41–passim. [PubMed] [Google Scholar]
  21. Schottenfeld D., Berg J. Incidence of miltiple primary cancers. IV. Cancers of the female breast and genital organs. J Natl Cancer Inst. 1971 Jan;46(1):161–170. [PubMed] [Google Scholar]
  22. Smith P. G., Doll R. Mortality among patients with ankylosing spondylitis after a single treatment course with x rays. Br Med J (Clin Res Ed) 1982 Feb 13;284(6314):449–460. doi: 10.1136/bmj.284.6314.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. van Leeuwen F. E., Somers R., Hart A. A. Splenectomy in Hodgkin's disease and second leukaemias. Lancet. 1987 Jul 25;2(8552):210–211. doi: 10.1016/s0140-6736(87)90782-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES